KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 161 filers reported holding KARUNA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57,491 | -91.5% | 340 | -89.1% | 0.00% | -100.0% |
| Q2 2023 | $678,524 | +724.6% | 3,129 | +590.7% | 0.00% | – |
| Q1 2023 | $82,283 | -75.9% | 453 | -74.0% | 0.00% | -100.0% |
| Q4 2022 | $342,107 | -78.6% | 1,741 | -86.2% | 0.00% | -66.7% |
| Q2 2022 | $1,601,000 | +1077.2% | 12,655 | +1081.6% | 0.00% | – |
| Q1 2022 | $136,000 | -87.0% | 1,071 | -86.6% | 0.00% | -100.0% |
| Q4 2021 | $1,043,000 | +1411.6% | 7,964 | +1307.1% | 0.00% | – |
| Q3 2021 | $69,000 | -90.1% | 566 | -90.8% | 0.00% | -100.0% |
| Q2 2021 | $699,000 | -6.7% | 6,133 | -1.6% | 0.00% | 0.0% |
| Q1 2021 | $749,000 | +142.4% | 6,233 | +105.2% | 0.00% | 0.0% |
| Q4 2020 | $309,000 | +291.1% | 3,037 | +328.3% | 0.00% | – |
| Q2 2020 | $79,000 | +92.7% | 709 | +23.1% | 0.00% | – |
| Q1 2020 | $41,000 | – | 576 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
| Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
| Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
| Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
| First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
| Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
| Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
| Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
| DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |